Nabgen, Inc.
Biotechnology company · Durham, North Carolina, United States
Nabgen, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2019. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $100,000 sold in a notice filed in 2022.
Nabgen at a glance
What does Nabgen do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.6 million in total (2020 to 2025). NIH funding came from the National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $100,000 sold (2022).
Frequently asked questions about Nabgen
Where is Nabgen headquartered?
Nabgen, Inc. is headquartered in Durham, North Carolina, United States.
What does Nabgen do?
Nabgen, Inc. is a biotechnology company.
When was Nabgen founded?
The earliest incorporation on record for Nabgen, Inc. is in 2019, according to public company registers.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences